If pharma wants to adopt continuous manufacturing, it must employ control procedures to ensure quality.

With approximately 80 percent of new drugs suffering from poor solubility and bioavailability, understanding solid form is more important than ever.

Joint letter from eight trade associations warns of “supply disruptions to life-saving medicines.”

A small-molecule drug has shown its ability to diminish HIV reservoirs.

High-throughput excipient discovery looks set to boost oral bioavailability.

The FDA aims to reduce drug prices with a more competitive market - and generics are key.

Will pharma adopt distributed ledger technology for data management within the next five years?

Multistep continuous-flow manufacturing is easier said than done. But Eli Lilly has found a way…

In 100 years, medicine is likely to be vastly different to what we can predict – or even imagine.

Initial research into the uses of medical cannabis suggests applications across a range of diseases, but research is needed to realize cannabis’ full medical potential.